跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ural Effervescent Granules - HSA Drug Approval Details
Approvals
/
HSA
/
Ural Effervescent Granules
Approved
THERAPEUTIC
Ural Effervescent Granules
Aspen Pharma Pty Ltd
🇸🇬 Health Sciences Authority
Approval Date
Jun 26, 2013
Approval ID
b6cc5d770629d037
Company
Aspen Pharma Pty Ltd
Type
Therapeutic
Approval Details
Approval Id
b6cc5d770629d037
Drug Name
Ural Effervescent Granules
Product Name
Ural Effervescent Granules
Approval Number
SIN14374P
Approval Date
2013-06-26
Registrant
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence Holder
ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
GRANULE, EFFERVESCENT
Route Of Administration
ORAL
Atc Code
G04BX
Atc Item Name
其它泌尿药
Pharma Manufacturer Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Company Detail Path
/organization/abbott-laboratories-singapore-private-limited
Active Ingredients
Sodium Bicarbonate
1.76g
Sodium Citrate Anhydrous
0.63g
Citric Acid Anhydrous
0.72g
Tartaric acid
0.89g
CITRIC ACID ANHYDROUS
0.72 G
SODIUM BICARBONATE
1.76 G
SODIUM CITRATE ANHYDROUS
0.63 G
TARTARIC ACID
0.89 G
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 26, 2013
Approval ID
b6cc5d770629d037
Type
Therapeutic
Back to HSA Approvals